FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

NEULANDLAB Consensus Forecast

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
725
Consensus Potential
100.00%

NEULANDLAB Price Target Potential

BrokerageTargetPotential

NEULANDLAB Targets in FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 10,119.5 for NEULANDLAB
100% Bullish
0% Bearish
See buy or sell ideas on FrontPage Forums >>

NEULANDLAB Ratings

Long term NEULANDLAB rating by FrontPage users
5/5 (1 Ratings)

1 NEULANDLAB share price target reports by brokerages below. See what is analyst's view on NEULANDLAB share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. NEULANDLAB Forum
  3. NEULANDLAB Price Target

NEULANDLAB Share Price Target

NEULANDLAB Share Price Target - Broker Reports - 2019

19-Aug-19
Price @ Call: 504.1
Target: 725
BUY
We maintain BUY on NLL following a mixed quarter. Our TP is revised to Rs 725 (14x FY21E EPS). The scale up in lucrative products like Salmeterol and Austedo remain key triggers for improvement in operational performance.
... Read more
15-Feb-19
Price @ Call: 583.15
Target: 830
BUY
Neuland Labs (NLL) reported encouraging numbers with 41% YoY revenue growth and a 73% YoY jump in EBITDA in 3QFY19. However, EBITDA margin remained muted at 9% of sales (in line) on account of continued raw material pressure, underutilized facilities and inferior business mix. PAT at Rs 46mn was up 5x YoY. Beleaguered by several issues like: (1) spike in key raw material prices, (2) delay in Salmeterol approval in the US, and (3) negative operating leverage due to underutilized plants; NLL’s FY19 performance has been a repeat of the previous year. However, the company has been able to report robust revenue growth of 34% YoY over 9MFY19, aided by resolution of capacity issues. With strong visibility on softening of raw material price hikes, backward integration for key molecules like Cipro/ Levetiracetam, scale up in high margin segments of Niche API/ CMS, increased contribution from Unit 3, and a significant ramp up in the generic Salmeterol market in the US by 2HFY20; we expect ~14% revenue CAGR, ~900bps EBITDA margin expansion and ~5x jump in earnings over FY19-21E. We are also enthused with NLL’s progress in the CMS segment with the inclusion of 4 new commercial projects in 3Q. Remain bullish on the stock and maintain BUY with a TP of Rs 830 (14x Dec-20E EPS).
... Read more

NEULANDLAB Share Price Target - Broker Reports - 2018

12-May-18
Price @ Call: 793.56
Target: 1000
BUY
15-Mar-18
Price @ Call: 697.1
Target: 1065
BUY

NEULANDLAB Share Price Target - Broker Reports - 2017

26-Sep-17
Price @ Call: 993
Target: 1318
BUY

NEULANDLAB Share Price Target - Broker Reports - 2016

25-Aug-16
Price @ Call: 1024.1
Target: 1280
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • NEULANDLAB Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 32,148
    Upside Target 22,148
    Upside Target 12,148
    Pivot2,148
    Downside Target 12,148
    Downside Target 22,148
    Downside Target 32,148
  • NEULANDLAB Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 32,395.6
    Upside Target 22,317.8
    Upside Target 12,205.6
    Pivot2,127.8
    Downside Target 12,015.6
    Downside Target 21,937.8
    Downside Target 31,825.6
  • NEULANDLAB Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 33,307.47
    Upside Target 23,018.73
    Upside Target 12,569.77
    Pivot2,281.03
    Downside Target 11,832.07
    Downside Target 21,543.33
    Downside Target 31,094.37
  • NEULANDLAB Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 32,148
    Upside Target 22,148
    Upside Target 12,148
    Pivot2,148
    Downside Target 12,148
    Downside Target 22,148
    Downside Target 32,148
  • NEULANDLAB Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 32,317.8
    Upside Target 22,245.22
    Upside Target 12,200.38
    Pivot2,127.8
    Downside Target 12,055.22
    Downside Target 22,010.38
    Downside Target 31,937.8
  • NEULANDLAB Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 33,018.73
    Upside Target 22,736.93
    Upside Target 12,562.83
    Pivot2,281.03
    Downside Target 11,999.23
    Downside Target 21,825.13
    Downside Target 31,543.33
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020